Frontiers in Cell and Developmental Biology · Nov 16, 2026
The inflammation-senescence axis in colorectal cancer: mechanistic evidence, translational strategies, and age-stratified considerations
By Hui Zhang, Jing-Xian Yan, Ding-Guo Pan et al.
Colorectal cancer (CRC) remains a major global health burden. Overall CRC incidence has declined or stabilized in several countries, primarily reflecting trends in late-onset CRC (LOCRC). Early-onset CRC (EOCRC), defined as CRC diagnosed before 50 years of age, has increased substantially in recent decades. The "inflammation-senescence axis" provides a conceptual framework integrating chronic low-grade inflammation, cellular senescence, and immunosenescence as interconnected hallmarks that potentially shape the CRC microenvironment and disease progression. In this review, we provide a comprehensive overview of the mechanistic evidence and translational strategies defining the inflammation-senescence axis in CRC, much of which has been established in late-onset CRC (LOCRC). We then incorporate essential age-stratified considerations, contrasting LOCRC with EOCRC, given that younger patients lack decades of accumulated age-associated molecular and cellular damage. We evaluate how the axis diverges in EOCRC across inflammatory pathways, cellular senescence, metabolic reprogramming, gut microbiota alterations, and tumor-microenvironmental dynamics. We highlight EOCRC-specific features, particularly its unique immune microenvironmental landscape, and outline potential precision intervention strategies. A systematic, age-stratified characterization of the inflammation-senescence axis is now needed to guide prevention and therapy across the CRC continuum.